Thinking about applying for your first NIH award?  Trying to improve your score? 
Just curious about what goes on inside the Study Section?  Then this session is for you!

The Research Development Office and the College of Liberal Arts and Sciences Grant Support Office are presenting a NIH Reviewer Panel Discussion and Q&A session on Thursday, December 10 from 1pm-2pm. This panel will provide an opportunity to hear from five accomplished NIH investigators regarding their participation in the NIH review process, including how this has impacted their grant writing efforts. Note: This information is also relevant to NIH Fellowship applications (F31/F32).


Joshua Weiner - Moderator 
Associate Dean for Research
College of Liberal Arts and Sciences
Professor, Biology

Keri Hornbuckle
Civil and Environmental Engineering 

Bob McMurray
Psychological and Brain Sciences

Peggy Nopoulos

Aliasger Salem
Pharmaceutical Sciences


Panelist Bios

Joshua Weiner: Joshua Weiner is the Associate Dean for Research in CLAS, Professor of Biology, and an Associate Director of the Iowa Neuroscience Institute, and focuses his research on molecular mechanisms of neuronal differentiation and neural circuit formation. His research has been continuously funded since 2004 through multiple National Institutes for Health grants and foundation awards. He has extensive experience reviewing F30/F31/F32 NRSA graduate and postdoctoral fellowships, having served for many years on the F03A study section, as well as reviewing R01/R03/R21 applications as an ad hoc member of the NDPR study section and several special emphasis panels.

Keri Hornbuckle: Keri Hornbuckle is the Donald E. Bently Professor of Engineering and Professor of Civil & Environmental Engineering.  She is the Director of the Iowa Superfund Research Program (ISRP), a P42 multi-project interdisciplinary research center funded by the National Institute for Environmental Health Sciences (NIEHS/NIH).   Dr. Hornbuckle’s research addresses the sources, transport, and fate of persistent organic pollutants (POPs) in natural systems, including both legacy and emerging pollutants. Her research has also been funded by the Great Lakes National Program Office of the U.S. EPA, and the National Science Foundation.  She was awarded an early CAREER development award from NSF. She has participated in reviews of NIESH/NIH P42 centers, NIEHS/NIH P30 centers, NSF IGERTs, NRTs, and CAREER applications, and USEPA STAR grants.

Bob McMurray: Bob McMurray is an F. Wendell Miller Professor in the Dept. of Psychological and Brain Sciences.  He is the director of the DeLTA Center.  His research investigates language and reading and their development in typical children, adults, and people with hearing loss.  His work has been funded by the NIH, NSF and IES.  He has reviewed for multiple programs at NSF and has reviewed NIH grants under both the K and R programs.

Peg Nopoulos: Peg Nopoulos is Professor and Chair in the Department of Psychiatry. She is a physician-scientist who does clinical research in brain imaging with an emphasis on studying and treating Huntington’s disease.  She has had continuous NIH funding of her research (including large multi-site studies) for more than 20 years and also has an NIH training program.  She has been involved in NIH grant reviews since 2006 and has reviewed NIH R awards, K awards, and Center grants.

Aliasger Salem: Aliasger Salem is the Bighley Chair and Professor of Pharmaceutical Sciences and head of the Division of Pharmaceutics and Translational Therapeutics. His research interests primarily focused on self-assembling systems, the rational design of novel drug and gene delivery systems, and on the development of vaccines that stimulate potent antigen-specific immune responses. He regularly serves on international and national grant review panels for organizations that include the American Cancer Society, the National Institutes for Health, and the Department of Defense: Congressionally Directed Medical Research Programs. In particular importance and relevance to this panel, Dr. Salem is currently a permanent member of the NIH Developmental Therapeutics (DT) study section until 2025 where he regularly reviews R01, R21, R03 and other grant funding mechanisms up to three times a year. He has also served as a site visitor and NIH grant reviewer for center grant applications and renewals.



Register here to receive the Zoom link and submit questions ahead of time.


Please email with any questions.

Sponsored by

Research Development Office and CLAS Grant Support Office